ITEMS OF INTEREST TO THE IMAGING RESEARCH COMMUNITY:
CIP Web Site: http://www.cancer.gov/bip
- Current Requests for Proposals: N01CM17004-28 Ultrasound Research Interface
Due: 04/16/2001, Issued: 03/02/2001
The National Cancer Institute (NCI) solicits contract proposals from ultrasound manufacturers to develop and evaluate ultrasound research interfaces. The purpose of the ultrasound interfaces is to provide expanded control over a wide range of imaging parameters on the host ultrasound imaging system, and thus significantly expand the system's performance for research applications. It is envisioned that these ultrasound interfaces will be software add-ons to continuously evolving scanner control software on the host ultrasound system. (Part III, Section J.2.Statement of Work Attachment 1).
- High Resolution Imaging in Small Animals with PET, MR and Other Modalities
MEETING ANNOUNCEMENT: HiRES 2001
High Resolution Instrumentation, Applications and Animal Handling
DoubleTree Hotel and Executive Meeting Center, Rockville, Maryland, USA
September 9-11, 2001
Long abstracts should be submitted via email to email@example.com. Abstracts should be no more than 1500 words long and must be submitted as plain-text e-mails. Authors may attach one image file in TIFF format to accompany the long abstract. The submission deadline is May 1, 2001.
Sponsored by: Society for Molecular Imaging, National Cancer Institute, Academy of Molecular Imaging
- REMINDER ON THE NEED FOR IACUC APPROVAL PRIOR TO PEER REVIEW (OD-01-008)
On May 1, 2000, the NIH announced that beginning with applications submitted for the January 2001 Council round, IRB approval is no longer required prior to NIH peer review of an application which involves human participants. (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-031.html). At this time, however, there is no change in the NIH policy for submission of IACUC approval when animal studies are involved. IACUC approval is still required of all such applications either when the application is submitted, or within 60 days thereafter; otherwise, the application cannot be peer reviewed.
- SHARED RESOURCES FOR SCIENTISTS NOT AT NCI FUNDED CANCER CENTERS (NCI) (CA-01-020)
Letter of Intent Due: June 5, 2001; Application Receipt Date: July 10, 2001
This Request for Application (RFA) requests applications to establish cancer-related research resources to provide new sources of technical support and research materials to advance cancer research. Increasing the availability of core resources is expected to improve the ability of cancer investigators to conduct research and to thereby facilitate scientific progress. To be eligible, applicant institutions must not have an NCI funded Cancer Center.
- MOLECULAR TARGET DRUG DISCOVERY FOR CANCER: COMPETING SUPPLEMENTS (NCI) (PAR-01-046)
Letter of Intent Receipt Date: May 17, 2001; Application Receipt Date: June 14, 2001
This Program Announcement (PA) replaces PAR-00-062, which was published in the NIH Guide on February 18, 2000.
The NCI is reorganizing its drug development programs from early drug discovery phases to the conduct of clinical trials in order to bring forward new types of agents based on strong rationales. The plan also involves changes in the clinical evaluation of new agents that will include appropriate measurements to verify target modulation. Competing supplements to existing NCI-funded grants should arise from projects that could extend ongoing work toward the identification or validation of molecular targets or their development into a screening tool.
- MOLECULAR TARGET DRUG DISCOVERY FOR CANCER: EXPLORATORY GRANTS (PAR-01-045) (NCI)
The Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), and the Chemoprevention Agent Development Research Group, the Division of Cancer Prevention, NCI invite exploratory/developmental grant applications (R21) to exploit molecular targets for drug discovery. New insights into our understanding of cancer cell biology provide a new opportunity for a fundamental re-ordering of approaches to cancer drug discovery.
- TECHNOLOGY DEVELOPMENT FOR BIOMEDICAL APPLICATIONS: PHASED INNOVATION AWARD (R21/R33) (NCRR) (PAR-01-057)
Application Receipt Dates: June 1 and October 1 annually
The National Center for Research Resources invites innovative applications for (1) the development of new and improved instruments or devices, (2) the development of new methodologies, or (3) the development of software to be used in biomedical research.
- SBIR Advanced Technology - (NIAID) (SBIR-AT-NIAID) (PA-01-052)
This Program Announcement, SBIR-AT-NIAID, invites grant applications for Small Business Innovation Research (SBIR) projects with award duration and amounts greater than those routinely allowed under the SBIR program. This program announcement replaces PAR-00-126 that appeared in the July 26, 2000 issue of the NIH Guide. This program announcement includes instructions for applications for funds in excess of $500,000 annual total cost and new contact listings for inquiries.
- The NCI Scholars Program (NCI) (CA-01-026)
Letter of Intent Receipt Date: May 8, 2001; Application Receipt Date: June 12, 2001
The purpose of the NCI Scholars Program is to provide an opportunity for outstanding new investigators to begin their independent research careers first within the special environment on the intramural campuses of the National Cancer Institute (NCI) and second to continue their careers at an institution of their choice.
Other Government Agenices
- September 2000 Brochure: Presidential Early Career Scientist and Engineer Awards
The Presidential Awards are intended to recognize some of the finest scientists and engineers who, while early in their research careers, show exceptional potential for leadership at the frontiers of scientific knowledge during the twenty-first century. Replaces pecase99. The guidelines for 2001 PECASE awards are described in the CAREER program brochure (NSF 00-89), available from the NSF CAREER Web page at: http://www.nsf.gov, select "Crosscutting Programs," then "CAREER."
- Department of Defense Breast Cancer Research Program for Fiscal Year 2001
Pre-proposal due: March 14, 2001; Full Proposal due: June 27, 2001 (see announcement)
The Fiscal Year 2001 (FY01) Defense Appropriations Act provides $175M to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative research directed toward the eradication of breast cancer. The CDMRP is requesting proposals on breast cancer research in two separate program announcements. This program announcement (Program Announcement I) is requesting proposals in the following three award mechanisms: CTR, C-CTR, and Breast Cancer Center of Excellence Awards.
- Department of Defense Prostate Cancer Research Program for 2001
The Congressionally Directed Medical Research Programs (CDMRP) is requesting proposals for prostate cancer research and training in two separate program announcements. This program announcement (Program Announcement II) requests proposals in five newly established PCRP award mechanisms: Prostate Cancer Clinical Trial Awards, Prostate Cancer Consortium Development Awards, Health Disparity Training - Prostate Scholar Awards, Health Disparity Research - Prostate Scholar Awards, and Historically Black Colleges and Universities Collaborative Partnership Training Awards.
Proposal receipt deadline for the Consortium Development Award is August 29, 2001. Proposal receipt deadline for all other mechanisms is June 6, 2001.
- Lawrence Livermore National Laboratory Seeks Partner(s) to Evaluate and Commercialize Cancer Treatment Computational Model
Primary Sponsor: Lawrence Livermore National Laboratory
- Defense Advanced Research Projects Agency (BAA01-26 BIO-COMP)
Proposal Deadline: May 3, 2001
The Information Technology Office (ITO) of the Defense Advanced Research Projects Agency (DARPA) has issued a call for proposals in their new Bio-Computation Program. The program is aimed at exploring and developing computational methods and models at the biomolecular and cellular levels.
- American Cancer Society Research Scholar Grants for Beginning Investigators
Application Deadline: April 1 and October 15.
Awarded to investigators in the first eight years of their independent research careers to support basic, preclinical, clinical, and epidemiologic research projects. Initial awards are made for up to four years and for up to $250,000 per year.
- The Brain Tumor Society
Application Deadline: April 3, 2001
The Brain Tumor Society is awarding grants to fund basic scientific research directed at finding a cure for brain tumors. Grants are awarded annually for up to a two-year period, at a maximum of $50,000 per year. Grants may be used for start-up projects or supplementary funding. Funds cannot be used for indirect costs.
- Introduction to Grantsmanship Workshop
Saturday, May 19, 2001
Royal York Hotel, Toronto, Canada
Held in conjunction with the Association of University Radiologists 49th Annual Meeting.
Meeting URL: http://www.aur.org/html/annual_meeting.shtml
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (firstname.lastname@example.org).
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7440
Tel: 301 496 9531
Fax: 301 480 3507